Alternatives to Koneksa

ClinCapture's mission is to create software that saves lives. ClinCapture's technology reduces the cost of clinical trials. It streamlines data capture and protects patient privacy. Clincapture is a platform that facilitates the evaluation and development drugs, biologics and devices that have the potential to treat a wide variety of medical conditions or diseases.

Castor offers an intuitive and comprehensive platform for managing clinical trial data, focusing on electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). The platform is optimized for decentralized trials, providing seamless tools for remote patient engagement and data collection. With real-time reporting, Castor helps researchers track trial progress and make data-driven decisions. The solution ensures compliance with industry regulations such as HIPAA, GDPR, and 21 CFR Part 11, making it ideal for life sciences organizations looking to enhance trial efficiency while maintaining high data integrity.

At PathAI, we are dedicated to enhancing patient outcomes through trustworthy AI-driven technology and meaningful partnerships, with the goal of delivering the most precise diagnoses and effective treatments to patients. Our innovative translational platform, supported by our skilled team of scientists, biostatisticians, and machine learning experts, uncovers and examines new cellular and tissue patterns to identify pathology-related features that yield groundbreaking insights throughout all stages of drug development and various therapeutic domains. By employing dependable and consistent technology, our platforms aim to reduce observer variability and enhance patient selection and stratification, ensuring that the most suitable patients are included in each trial, thereby boosting the likelihood of successful outcomes. Additionally, our technology establishes the most accurate cut points, allowing us to enhance precision and maximize the number of patients who test positive for biomarkers, ultimately contributing to more effective treatments. This commitment to excellence positions us at the forefront of transforming healthcare through advanced analytics and collaboration.

Numerous organizations globally rely on IQVIA to accelerate the drug development process, guarantee the safety and quality of products, enhance commercial efficacy, deliver appropriate treatments to patients, and ultimately promote improved health outcomes by facilitating access to and delivery of healthcare. Transform your approach to clinical development by seamlessly integrating data, technology, and analytics to streamline your trials. The outcome? Quicker decision-making and minimized risks, enabling you to provide transformative therapies at a faster pace. With its expertise rooted in data, sophisticated analytics, and deep industry knowledge, IQVIA offers tailored capabilities to clients throughout the healthcare landscape. Stay informed by exploring the latest insights and updates from IQVIA's data scientists, healthcare professionals, researchers, and other industry experts on crucial topics that resonate with your interests. From emerging industry developments to practical applications of our capabilities, a wealth of information awaits you here. Engaging with this content also empowers you to stay ahead in a rapidly evolving healthcare environment.

The LARVOL CLIN platform offers a robust suite of AI-driven data intelligence and analytics specifically designed for professionals in oncology and drug development, consolidating over 100,000 cancer clinical trials along with comprehensive results, digitized Kaplan-Meier curves, forest plots, and live social media feedback from a network of more than 5,000 oncologists. Users benefit from a unified interface that allows for searches by condition, intervention, or trial ID, complemented by expert-curated insights and visually engaging dashboards that facilitate informed decision-making. Additionally, the platform encompasses features such as conference tracking, extensive biomarker and diagnostics databases, and market intelligence reports sourced from over 25,000 entities, including regulatory communications, clinical trial registries, and various scientific congresses. Designed to aid pharmaceutical and biotech teams in deciphering trial outcomes, trends, mechanisms of action, biomarker identification, and disease pipelines, it employs advanced search filters, heat maps, and real-time alerts. This comprehensive approach ensures that users remain well-informed and equipped to make strategic decisions in a rapidly evolving field.

The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.

AcceleTrial™ eliminates uncertainties in identifying and activating clinical trial sites. Our Study Start-up Management System (SSMS) relies on objective data rather than self-reported information. With AcceleTrial™, you gain access to a comprehensive database of thousands of globally ranked and indexed sites, evaluated based on their specific therapeutic expertise, clinical trial experience, and patient data. This system allows for an objective pairing of the most suitable sites worldwide with the relevant data on expertise, experience, and patient demographics for your clinical trials. You can swiftly engage the right sites to commence patient enrollment through AcceleTrial™'s automated “push and pull” functionality, available in multiple languages. The platform simplifies the process of gathering necessary documents with pre-filled templates and enables real-time tracking of activities. You can begin utilizing the system immediately, as it is a cloud-based solution that requires minimal IT infrastructure or training. Moreover, AcceleTrial™ can be seamlessly integrated with CTMS or other existing clinical trial management systems for enhanced efficiency. This ensures a streamlined approach to clinical trial management, allowing researchers to focus on their core objectives.

Mahalo Health is an integrated digital health platform aimed at expediting the creation of patient-focused digital health solutions and clinical trials. By providing a variety of prebuilt modules, Mahalo facilitates the swift launch of customizable white-label applications that cater to particular therapeutic fields. The platform boasts comprehensive data capabilities, featuring a predictive health engine for forecasting diseases and diagnoses, a behavior modification engine to encourage beneficial patient behaviors, and a notification system that ensures timely communication through push notifications, SMS, or emails. Committed to maintaining high security and compliance standards, Mahalo follows regulations such as HIPAA, GCP, ISO27001, and GDPR. Its extensive range of services encompasses multiple therapeutic areas, including diabetes, cognitive health, cardiovascular issues, musculoskeletal conditions, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Additionally, Mahalo Health empowers healthcare providers with tools to enhance patient engagement and outcomes through its innovative digital solutions.

TrialPoint™ electronic data capture (EDC) is highly adaptable and user-friendly, earning the approval of coordinators everywhere. Our skilled data managers specialize in transforming clinical protocols into accessible metadata dictionaries, ensuring that TrialPoint™ is tailored to your needs rather than hindering your processes. The platform is capable of accommodating any randomization string, media uploads, or coding dictionaries, and it has the functionality to obscure treatment assignments from users. To enhance timely data collection, the system proactively determines visit windows and dispatches alerts and reminders, helping to keep the entire team aligned and on track. In the current landscape, incorporating patient-reported health outcomes and quality of life questionnaires is common in clinical trials, often leading to protocol adherence challenges. Explore TrialPoint's electronic patient-reported outcomes (ePRO) module, which can be customized to accommodate any quality of life questionnaire or patient diary, providing a seamless experience for participants. Ultimately, this flexibility not only facilitates compliance but also enhances the overall quality of the data collected in clinical trials.

Suvoda is a worldwide leader in clinical trial technology, focusing on intricate, life-preserving studies in fields like oncology, central nervous system conditions, and rare diseases. Established in 2013, the company provides a comprehensive platform featuring Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all aimed at streamlining essential patient interactions. Their innovative software design guarantees a fluid user experience, enabling accurate randomization, efficient drug supply management, and immediate data collection. With a strong commitment to improving patient understanding and alleviating the demands on trial sites, Suvoda's offerings are designed to evolve alongside the increasing complexities of clinical trials. Based near Philadelphia, with additional offices across Europe and Asia, Suvoda has successfully supported over 1,500 trials in more than 85 countries, showcasing their global reach and expertise in the field. Their dedication to innovation and excellence positions them as a vital partner in the advancement of clinical research.

Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.

Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.

We offer a comprehensive tracking solution designed specifically for clinical trials. With a simple download onto your trial managers' mobile devices, you can relax as TruLab's advanced blockchain technology handles all the complexities. There's no need to wait for samples to arrive at a central lab to identify potential issues; instead, you can detect data anomalies in real-time as samples progress through the clinical trial process. TruLab facilitates continual remote accessioning of samples, addressing the significant concern that 20% of samples are either lost or deemed unusable during late-stage trials. This situation is unacceptable from ethical, logistical, and financial perspectives. Furthermore, with sample collections increasingly taking place at participants' homes, new challenges in tracking these samples arise. TruLab effectively monitors samples wherever they are located, ensuring that they are accounted for from residences to repositories, thus enhancing the overall integrity of the clinical trial process. By providing seamless tracking capabilities, TruLab empowers trial managers to mitigate risks and improve outcomes.

HumanFirst is establishing the necessary operational framework to facilitate decentralized trials and provide distributed care directly at home. Our workflow management platform equips your team with essential tools for tailored remote monitoring solutions. The timeline-driven interface supports every stage from evaluation to deployment and management. We have cataloged connected sensor technologies in Atlas, classifying physiological and behavioral metrics into over 150 distinct categories. Our expertise covers medical conditions across more than 25 therapeutic areas. Utilizing the open-access V3 Framework, we have analyzed more than 500,000 pieces of evidence to identify optimal technologies for digital endpoint measurement. By implementing remote monitoring, we aim to enhance patient outcomes significantly. You can also showcase your connected product on Atlas, contributing to an expansive network of innovations. Our commitment to open-access publications has garnered recognition in leading peer-reviewed journals, emphasizing our dedication to advancing healthcare. HumanFirst is dedicated to promoting safe, effective, and equitable healthcare practices in the home environment, ensuring that every patient receives the best care possible.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

Modern Interactive Response Technology (IRT) systems are becoming more intricate. The significance of flexible and customizable IRT cannot be overstated, as this technology serves as the primary source for essential data, including recruitment metrics, clinical trial attrition rates, patient attendance, and more. It is vital to select a platform that is intuitive, optimized for mobile use, and all-encompassing—underpinned by high standards of quality, adaptability, and expertise. Embrace a partnership that offers profound therapeutic knowledge tailored to the contemporary risk-based eClinical landscape. By merging advanced technology with specialized knowledge and a dedication to exceptional service, we enhance clinical trials to achieve favorable patient results. Our extensive understanding of clinical processes and supply chain dynamics fosters innovation, granting clients greater control over their Randomization and Trial Supply Management (RTSM) protocols. Our cutting-edge tools elevate quality assurance, improve site productivity, and enhance patient adherence significantly. Furthermore, our IRT platform is adaptable enough to cater to a wide array of studies, with the capability for full validation and deployment in just 30 days, ensuring efficiency in clinical trial operations. This swift implementation can lead to more timely data collection and improved overall trial management.

DoubleJump Interchange is a collaborative platform hosted in the cloud that seamlessly merges data from both clinical and real-world environments to enhance cooperation between researchers and healthcare practitioners, ultimately aiming to improve the health of consumers. Consumers, along with their extended care teams, benefit from a diverse array of health information sourced from hospitals, clinics, and remote monitoring technologies, enabling them to engage in personalized, socially supported, and timely disease prevention and management. Researchers are provided with a rich pool of clinical, molecular, and real-world data, facilitating the discovery of new disease targets and identifying biomarkers that predict treatment responses effectively. By sharing clinical expertise throughout a network of healthcare providers, the platform strives to advance the principles of precision medicine. Furthermore, it accelerates the accessibility of intricate data sets, thereby driving innovation in both translational research and healthcare delivery processes. This interconnected approach not only enhances collaboration but also supports the overarching goal of elevating overall consumer health outcomes.

Science 37 is a pioneering clinical research organization that focuses on decentralized clinical trials through its innovative Metasite model, which eliminates the need for physical proximity, allowing patients to engage in studies from virtually anywhere. This method significantly broadens accessibility, reaching over 90% of individuals who might be excluded from conventional site-based research, and harnesses the recruiting capabilities equivalent to 20 sites in one location, thereby offering patients the flexibility they desire. The Metasite operates on a proprietary platform that not only streamlines study orchestration but also facilitates the workflow for both patients and research staff, all while efficiently capturing study data without manual reentry. By centralizing personnel, processes, and technologies, this approach guarantees built-in protocol compliance, which leads to enhanced compliance rates and the collection of high-quality data. Science 37's dedicated in-house medical teams, telemedicine investigators, and mobile nursing professionals are well-versed in the conduct of remote trials spanning various therapeutic areas, thus ensuring comprehensive outreach. This commitment to innovative trial methodologies positions Science 37 at the forefront of transforming the landscape of clinical research.

Leapcure stands at the forefront of patient recruitment and engagement, bridging the gap between clinical trial sponsors and suitable participants. By leveraging cutting-edge technology and innovative methodologies, we aim to boost both trial enrollment and patient results. Our platform simplifies the recruitment process, allowing for the rapid and efficient identification of qualified candidates for clinical trials. Committed to enhancing medical research, Leapcure strives to make clinical trials more inclusive and impactful. We collaborate intimately with both sponsors and participants to ensure seamless and fruitful trial experiences, which play a crucial role in the advancement of new therapies and treatments. Through our efforts, we are not only improving access to clinical trials but also fostering a more efficient pathway for medical breakthroughs.

Clinion eCOA allows you to conduct decentralised clinical trials, with patients participating remotely. Clinion eCOA allows study participant to report their health from their home using their smartphone. This allows clinicians to monitor patients in real time. Clinion eCOA integrates seamlessly with Clinion EDC. Trial participants can input daily outcomes directly. This eliminates data duplication and transcription errors, and provides clinicians with a real time view of patient progress. Multilingual forms are supported by the eCOA app, which makes it easier for patients to engage and provides cleaner data. The eCOA app's decentralised nature allows for faster and wider patient recruitment.

With more than two decades of expertise in the fields of software publishing and clinical research, Arone delivers a comprehensive array of tools designed for the efficient entry and management of patient data for clinical research organizations. Our solutions are ready to use, and we offer tailored support to ensure your projects and studies are conducted effectively. Utilize a unified platform to gather and oversee patient data seamlessly. Arone facilitates patient randomization by randomly designating treatment types to study participants, which helps eliminate bias in research outcomes. Enhance the engagement of clinical trial participants by enabling them to enter their daily data conveniently. Additionally, our personalized support enhances the overall success of your research projects. Together, we strive to innovate and improve the clinical research landscape.

Speeding up the creation of crucial medications and ensuring that patients worldwide can access top-notch cancer treatment and research equally. Our technology is transforming how patients access cutting-edge medicines and participate in clinical trials. FICS is a groundbreaking software solution that facilitates the gathering of regulatory-compliant data throughout patient treatment. By integrating previously isolated and non-interacting applications into a comprehensive, seamless platform, FICS is making clinical trials more efficient, quicker, and of superior quality, ultimately enhancing patient outcomes in significant ways.

Data flows in from various channels, including EDC, EHR, smartphones, mobile devices, and central laboratories. Prism expertly integrates this diverse information and transforms it into usable knowledge. By combining user-friendliness with cutting-edge features, Prism EDC presents a modern approach to collecting and managing clinical trial data. Beyond traditional form-based data gathering, Prism also consolidates and organizes information from a wide range of sources. Additionally, Prism eSource offers a groundbreaking software solution that enables research teams to directly pull clinical trial data from a site's electronic health record (EHR). This innovation not only enhances efficiency and reduces costs compared to the existing model—where sites redundantly input the same data into multiple systems—but also speeds up the availability of new therapies to patients in need. As a result, the healthcare industry stands to benefit significantly from the streamlined processes that Prism facilitates.

AssisTek stands out as a frontrunner in cutting-edge clinical technology solutions tailored for clinical research, providing specialized software that optimizes and improves the process of gathering patient data. With a legacy of over 25 years, the company has successfully facilitated more than 800 clinical research trials spanning 46 therapeutic areas, which include upwards of 500 multinational Phase I–IV clinical trials. Their electronic Clinical Outcome Assessment (eCOA) solutions boast scalability, customization, and efficiency, backed by a reliable cloud-based technology platform. Among their extensive product offerings are the TEK eCOA Tablet, which accommodates any questionnaire utilized in clinical trials, TEK eDiary, enabling the collection of patient-reported outcomes from home, TEK Configurator for comprehensive project development in clinical trials, and TEK Study Portal, which consolidates eClinical tracking, training, and reporting into one convenient location. AssisTek's innovative systems and services have established them as the preferred partner for data collection and analytics, winning the trust of both patients and healthcare professionals alike. As they continue to evolve, AssisTek remains committed to enhancing the efficiency and accuracy of clinical research methodologies.

Lindus Health is transforming the landscape of clinical trials by providing an all-encompassing solution that yields quicker and more dependable outcomes. Our holistic methodology combines full-service CRO functions, operational site management, and cutting-edge technology, enhancing every facet of your study from initial design to final data delivery. Utilizing our nimble in-house technology, we accelerate the setup of sites and the recruitment of patients, tapping into a vast pool of over 30 million electronic health records to speed up enrollment. Our pricing model, which operates on fixed milestones and pay-on-results, aligns incentives effectively, removing the risk of unforeseen expenses and delays. With an impressive average satisfaction rating of 9.7 out of 10, our dedicated and experienced clinical operations team is committed to achieving excellence at every stage. Lindus Health has quickly broadened its global footprint, successfully conducting more than 91 trials across diverse therapeutic areas, such as metabolic health, women's health, diagnostics, and medical devices, all while maintaining a focus on innovation and quality in clinical research. This relentless pursuit of efficiency and reliability makes Lindus Health a leader in the industry.

The TCS ADD platform significantly enhances the speed at which pharmaceutical companies can bring products to market by streamlining the entire clinical research and development process, ultimately leading to more agile and secure clinical trials. By fostering digital ecosystems and simplifying the intricacies of data management, TCS ADD facilitates quicker access to innovative and effective medications for patients. This platform utilizes the TCS Decision FabricTM, an advanced cognitive artificial intelligence engine, alongside smart analytics and the Internet of Things, delivering exceptional business advantages to the pharmaceutical sector. It serves as a comprehensive, metadata-driven solution designed to uphold industry standards and sponsor requirements in clinical trials. Furthermore, this data science-oriented platform employs artificial intelligence and machine learning technologies to expedite decision-making, accelerate study initiation, and implement targeted interventions. By digitizing the entire supply chain management of clinical trials while prioritizing patient safety, this solution not only improves overall effectiveness but also enhances the patient experience throughout the trial process. Ultimately, TCS ADD represents a transformative approach to clinical trial management that aligns with the evolving needs of healthcare.

Advanced Health Intelligence (AHI) specializes in providing health risk assessments derived from digital biomarkers, facilitating proactive risk management for diverse global populations through innovative, easy-to-use smartphone applications. Our digital health assessments offer in-depth evaluations of cardiovascular, metabolic, and mental health risks. With FaceScan, users can obtain health vital estimates in just about two minutes by utilizing camera-sensor inputs on their web or smartphone devices. BodyScan empowers individuals to evaluate their body composition and dimensions, along with the associated health risks, all within the comfort and privacy of their own space. AHI's offerings ensure population risk stratification, enhanced access to preventive resources, contactless and non-invasive risk evaluations, and the ability to self-administer assessments while engaging with remote populations. Our distinctive array of healthcare technologies is protected by patents in numerous countries, highlighting our commitment to innovation in health management. Ultimately, AHI is dedicated to transforming the way people understand and manage their health risks through cutting-edge digital solutions.

Enhance the quality of your evidence with superior electronic Patient-Reported Outcomes (ePRO) and electronic Clinical Reported Outcomes (eClinRO). These Electronic Clinical Outcome Assessments, known as eCOA, evaluate patients' feelings and functionality during clinical trials effectively. By collecting clinical data in an electronic format, you can ensure that the data from your patients is not only high-quality but also in compliance with regulatory standards. In essence, eCOA eliminates the challenges related to paper diaries, such as issues with readability, transcription mistakes, and discrepancies in data. Furthermore, the FDA advocates for the use of ePRO. This involves patients providing insights into their health through various questionnaires or assessments, which may include evaluations of quality of life or activity levels. Clinician-reported outcomes, on the other hand, involve health assessments made by a clinician, with examples such as physical examinations like PASI. Additionally, performance outcomes gauge a patient's ability to complete specific tasks, such as performing a timed activity, thereby offering a comprehensive view of their health status. Ultimately, the transition to eCOA and its associated methods signifies a move towards more reliable and efficient clinical trial processes.

Enhance the quality of data management by directly capturing eSource data during patient interactions. This process incorporates integrated editing and validation mechanisms, allowing users to electronically gather high-quality information, which significantly minimizes errors and inquiries, while facilitating real-time remote oversight. By doing so, the study duration, expenses, and risks are significantly reduced. FDA-endorsed, this innovative eSource approach simplifies and modernizes clinical trials, effectively replacing slow, error-prone monitoring and the transcription process into electronic data capture (EDC) systems. Additionally, tailored for site users, ez-SourceDocx optimizes workflows, alleviates workloads, and ensures adherence to study protocols by guiding sites through properly sequenced visit procedures, which not only confirm the collection of all endpoint data but also encourage timely quality assessments by investigators. Ultimately, this comprehensive system enhances overall clinical trial efficiency and reliability.

Provide your patients with care beyond traditional face-to-face appointments by utilizing video consultations, remote monitoring, and digital therapeutic tools found in Oracle Health’s comprehensive virtual care solutions. Engage in active monitoring of essential health metrics, fostering a collaborative partnership between patients and clinicians through Oracle Health’s Remote Patient Monitoring features. Empower patients to leverage their personal devices for seamless access to their clinician’s monitoring programs. The health data collected during clinical workflows will generate timely alerts and notifications, enhancing responsiveness. Cater to patients in their own environments with a combination of video visits and Oracle Health Remote Patient Monitoring, alongside digital therapeutic functionalities. Promote the adoption of these tools among clinicians to improve their work-life balance and enable them to practice more effectively with integrated virtual care solutions. By extending care beyond the hospital's confines, you can continuously monitor critical health data directly within the electronic health record (EHR) system, ensuring comprehensive patient management. This approach not only enhances patient experience but also strengthens the overall healthcare delivery model.

Signant Health operates as a worldwide leader in evidence generation, striving to transform the landscape of clinical trials by connecting with patients in their environments and rethinking the route to validation. Their extensive range of clinical technology solutions includes electronic Clinical Outcome Assessments (eCOA), Electronic Data Capture (EDC), electronic clinician evaluations, and a cohesive eClinical platform. Additionally, they offer patient engagement solutions featuring a user-friendly app, eConsent for informed consent processes, and telemedicine functionalities. Furthermore, Signant Health delivers clinical data and analytics services, which include COA data analysis as well as the aggregation and interpretation of data. With a rich history spanning over three decades, they have played an instrumental role in supporting numerous trials and have been pivotal in hundreds of drug approvals, establishing themselves as a reliable ally for sponsors and CROs eager to provide high-quality data for informed trial decisions and regulatory submissions. Their commitment to innovation continues to shape the future of clinical research.

Explore our efficient screening tools designed to identify patients at a high risk for breast, colorectal, and other types of cancer. Progeny Clinical streamlines the management of family histories, risk assessments, and treatment options for your patients. You can gather family history information online and automatically create pedigrees prior to the clinic appointment. Modify existing pedigrees or create new ones at any time. Execute validated hereditary cancer risk assessment models with a single click, eliminating the need to re-enter data. Simplify the process by ordering genetic testing through Ambry Genetics. Monitor and analyze results from any laboratory without leaving the software environment. Enhance efficiency by generating letters, consultation notes, reports, and documents using custom templates that incorporate patient data fields. Utilize pre-configured or tailored data input screens to swiftly create custom queries and spreadsheet reports. Moreover, you can integrate a hyperlink within your electronic medical record to conveniently access the patient’s latest pedigree. This innovative approach not only saves time but also optimizes patient care and enhances workflow efficiency.

Deep 6 AI revolutionizes the patient enrollment process for clinical trials by changing how researchers pinpoint suitable candidates. By leveraging artificial intelligence and natural language processing, DEEP 6 AI efficiently sifts through both structured and unstructured patient information, enabling the identification of a larger pool of well-matched trial participants in mere minutes instead of the months typically required. The platform collaborates with leading health systems, pharmaceutical companies, and contract research organizations, positioning itself as an essential component of the clinical research ecosystem and significantly hastening the process for patients to access trials. In addition to expediting enrollment, Deep 6 AI’s innovative software evaluates structured data, like ICD-10 codes, alongside unstructured clinical information such as physician notes, pathology reports, and surgical documents that are often difficult to search through. This comprehensive analysis ensures that researchers can quickly find candidates who meet specific criteria, ultimately leading to faster delivery of groundbreaking treatments to those in need.

Uncover the most cutting-edge methods in the realm of clinical and patient-reported outcomes data. Our comprehensive solution transcends mere data entry, facilitating a genuinely patient-focused research experience. While our eCOA software is deeply rooted in principles of behavioral science, it has also been designed specifically by healthcare professionals to align with the needs of both sites and sponsors. By emphasizing personal identity, motivational intervals, and significant objectives, we stand out from other eCOA solutions. The Datacubed app features a user-friendly interface that allows participants to quickly engage with what truly matters. It has been highlighted that gathering data is now more straightforward than ever, thanks to our adaptable, user-friendly, and interactive application. As the need for flexibility in trial design continues to grow, we provide versatile data collection options that can be executed in person, remotely, or as a hybrid approach, catering to the diverse requirements of traditional, hybrid, and virtual clinical trials. This adaptability ensures that researchers can effectively capture the most relevant data, regardless of the study format.

Health Studio™ provides an innovative, all-encompassing AI platform that brings together patient care, clinical research, and remote monitoring into one cohesive system. By effectively linking wearables, medical instruments, and patient information, it offers immediate insights, optimizes workflows, and improves health outcomes, thus revolutionizing healthcare into a more interconnected and data-centric journey. This advancement not only benefits healthcare providers but also empowers patients through better access to their health information.

PicnicHealth serves as a bridge between patients and researchers, providing comprehensive and purpose-driven real-world data. By engaging with patients who willingly share their medical information for research purposes, we can create an extensive understanding of patient health that encompasses all their healthcare providers, rather than being limited to a single site or specialist. Our established patient communities and efficient recruitment methods through various direct-to-patient channels make it simple to assemble the right cohort of patients. In just ten minutes, patients can register and give consent, gaining access to their own medical records. If you currently have patients involved in ongoing registries or clinical trials, consider directing them to PicnicHealth for streamlined setup. Our research platform is designed to offer tailored real-world data at the individual patient level, allowing for precise specifications regarding the data elements to be extracted from medical records, such as doctors' notes and narrative text. This innovative, patient-focused approach not only enhances the data we gather but also encourages patients to play an active role in the research process. Ultimately, we believe that empowering patients in this way fosters a deeper understanding of health outcomes and improves the overall quality of research.

Data MATRIX offers a comprehensive SaaS solution specifically designed for clinical trials. Since its inception in 2009, the Data MATRIX team has specialized in the processing and analysis of clinical data, creating documents that comply with the standards set by the Russian Ministry of Health, FDA, and EMA. Our software streamlines clinical trial processes, allowing users to efficiently manage and track progress online. Before launching a project, we meticulously adjust and validate our software to ensure that every aspect is considered for optimal performance. With a proven track record of completing 180 projects for pharmaceutical companies, biotech firms, and CROs, our solutions have led 6 out of the top 10 Big Pharma companies to achieve a 15% reduction in R&D expenses. Our dedicated team members take pride in their involvement with professional organizations that connect clinical data professionals such as CDISC, ACDM, SCDM, biostatisticians like ISBC, and medical writers associated with EMWA and AMWA. By continually enhancing our offerings, we remain committed to driving innovation in the clinical research landscape.

REDCap Cloud serves as a comprehensive data-science platform that empowers organizations to gather, integrate, standardize, analyze, and disseminate clinical and research data that meets real-world and regulatory standards, all within a cohesive, standards-driven system. This platform facilitates the complete lifecycle of randomized clinical trials and real-world evidence research by providing diverse modules tailored for intricate trial design and execution, a centralized clinical data hub that integrates both eCRF and non-eCRF sources, AI/ML capabilities for real-time operational and data insights, and seamless connectivity to eSource and EHR systems. Additionally, it enhances patient engagement through tools like ePRO/eCOA and wearable devices, accommodating both hybrid and decentralized trial models. The analytics features include options for synthetic control arms and digital twins, ensuring adherence to global security compliance standards. Ultimately, REDCap Cloud is designed to mitigate data silos, eliminate vendor fragmentation, facilitate bidirectional data flows, and offer sponsors, CROs, and health systems comprehensive visibility and oversight regarding site performance, study data integrity, and regulatory preparedness. By streamlining these processes, organizations can achieve greater efficiency and effectiveness in their research endeavors.

Zelta is a cloud-powered platform for unified clinical data management and acquisition, designed to streamline and enhance clinical trial processes. Its modular architecture adapts to the unique demands of each study, enabling faster and more efficient outcomes. With capabilities such as electronic data capture, clinical operations management—including randomization and trial supply tracking—clinical trial management, and electronic trial master file functionality, Zelta supports comprehensive study oversight. It also enhances patient and provider engagement with electronic clinical outcome assessments and e-consent solutions. Built for studies across all phases, therapeutic areas, and global regions, Zelta offers an intuitive user experience with secure single sign-on access from anywhere. Its flexible and scalable design allows for seamless customization and integration with both native and third-party technologies, ensuring adaptability to diverse research needs.

Medable offers an innovative software solution designed for the research and execution of clinical trials via a decentralized platform. This technology is focused on actively engaging patients remotely to ensure the collection of the most accurate results. Additionally, patients can conveniently provide their consent for digital assessments from a distance, and the platform is tailored to comply with local languages and regulatory requirements. Optimize the decentralization of your protocol with our adaptable, modular digital and decentralized clinical trial (DCT) platform. Facilitate extensive remote screening on a global scale and achieve your enrollment goals more swiftly. Create any type of screening assessment to fit your needs. Enhance the clarity of consent documents with responsive designs suitable for web and mobile devices. Deliver remote eConsent experiences to patients that rival popular consumer digital interfaces. With the capability to adapt to local regulations and languages, we offer global flexibility that accommodates diverse needs. By engaging patients and alleviating the challenges associated with travel and time constraints of on-site visits, you can significantly enhance patient access and involvement in the study. Ultimately, this approach not only streamlines the clinical research process but also prioritizes patient convenience and participation.

IVR Clinical Concepts is a company that focuses on offering technology for virtual clinical trials and solutions for patient engagement. Their products feature electronic patient-reported outcomes and patient diaries, which are designed to enhance data quality by minimizing errors, thereby shortening timelines and reducing overall costs. Furthermore, they provide comprehensive patient recruitment and outreach services that emphasize outreach, pre-screening, and the collection of real-time data. The solutions for subject screening, registration, and randomization are characterized as modular, tailored, adaptable, and customizable. In addition to these services, IVRCC also delivers clinical trial material management solutions aimed at lightening the workload while ensuring greater control, along with eClinical integration services that work to unify data seamlessly. Their chart review services offer insights based on real-world data and clinical experiences. By prioritizing custom, modular, and adaptable solutions, IVRCC strives to enhance the patient experience and maximize the success rates of clinical trials. This commitment to innovation positions IVRCC as a leader in the industry, dedicated to improving the efficacy of clinical research.

Validated by scientific research, our objective solutions for monitoring drowsiness ensure that you exceed all safety requirements. Elevate your driver monitoring system to the highest standards in the industry. You can either license our innovative solution or validate your existing system against two decades of reliable data. Our technology has received commercial validation from Vale, one of the largest mining companies globally. Experience real-time management and reporting through our instant cloud-based platform. This represents a groundbreaking future, where we identify key biomarkers associated with neurological conditions while driving. You can oversee your team remotely with ease, utilizing our cloud monitoring system to analyze and report findings. User-friendly and safety-focused, Optalert stands at the forefront of the medtech industry, specializing in drowsiness and impairment detection for over 20 years. Our technologies are grounded in the principle of blepharometry, a term introduced by our founder, Dr. Murray Johns, which refers to the precise measurement of eyelid movement using sophisticated sensors or cameras. The evolution of our technology continues to advance, promising even greater innovations in the field.

We create innovative solutions that enhance and strengthen the clinical trial ecosystem. Our platform for Enrollment Performance Management is favored by research sites and relied upon by sponsors. It is utilized by 2,000 research sites in 26 countries and is endorsed by half of the world's top-20 biopharma companies. This enables sites to reduce time spent on repetitive and manual activities, facilitating a smoother patient progression. By minimizing redundant efforts, there are fewer logs, phone calls, and emails required from both sites and sponsors. Sponsors can proactively improve enrollment with immediate access to advanced pre-screening and enrollment metrics. Our remarkably straightforward patient recruitment and enrollment solution is trusted by over 1,800 sites worldwide. Gain access to impactful recruitment and enrollment insights, ensuring clinical trials are conducted faster and with greater predictability. By eliminating unnecessary tasks, sites can refocus their efforts on what truly matters: providing assistance to patients. Effortlessly manage recruitment across all trials, sponsors, or CROs with the ability to input information once and have it directed where it is needed most. This innovative approach not only streamlines the process but also enhances collaboration among all stakeholders involved in clinical trials.

Antidote serves as a recruitment platform for clinical trials, enhancing the speed of medical research by connecting patients with sponsors through targeted recruitment services and a user-friendly matching search engine. Addressing the challenge that more than 80% of clinical trials face delays due to participant shortages, Antidote equips sponsors with a vendor-neutral, centralized dashboard that streamlines referrals from any source, automates the outreach process for due diligence and owner letters, monitors enrollment and return on investment metrics in real-time, and offers insightful analytics on sites and candidates with updates every hour. For patients, Antidote's intelligent matching system simplifies the intricate inclusion and exclusion criteria into straightforward guided Q&A interactions, subsequently providing current listings of clinical trials and personalized notifications for new opportunities that match their profiles. The platform is designed to accommodate both bulk and individual record imports with automated validations, and it features user-friendly, multilingual interfaces that are optimized for mobile use. This innovative approach not only enhances the recruitment process but also fosters a more effective collaboration between researchers and potential participants.

Jeeva's patent-pending modular system is built on the most powerful cloud platform. One login from any browser-enabled device can be used to remotely screen patients, educate, enroll, send SMS, email and generate evidence including electronic patient-reported outcomes. They are tired of waiting for patient recruitment and retention to happen. It is crucial to provide sufficient evidence of safety and efficacy for investigational new medicines in order to receive regulatory agency approval. Jeeva is a great tool for saving time and money for patients, biopharma sponsors, and long-term follow up studies for gene therapy.